C-Reactive Protein Protects Against Acetaminophen-Induced Liver Injury by Preventing Complement Overactivation.
C-Reactive Protein Protects Against Acetaminophen-Induced Liver Injury by Preventing Complement Overactivation.
复制标题
C 反应蛋白通过防止补体过度激活来防止对乙酰氨基酚引起的肝损伤。
DOI:
10.1016/j.jcmgh.2021.09.003
复制
发表时间:
2022
影响因子:
7.2
通讯作者:
Wu Y
中科院分区:
文献类型:
--
作者:
Li HY;Tang ZM;Wang Z;Lv JM;Liu XL;Liang YL;Cheng B;Gao N;Ji SR;Wu Y
C-reactive protein (CRP) is a hepatocyte-produced marker of inflammation yet with undefined function in liver injury. We aimed to examine the role of CRP in acetaminophen-induced liver injury (AILI). The effects of CRP in AILI were investigated using CRP knockout mice and rats combined with human CRP rescue. The mechanisms of CRP action were investigated in vitro and in mice with Fcγ receptor 2B knockout, C3 knockout, or hepatic expression of CRP mutants defective in complement interaction. The therapeutic potential of CRP was investigated by intraperitoneal administration at 2 or 6 hours post–AILI induction in wild-type mice. CRP knockout exacerbated AILI in mice and rats, which could be rescued by genetic knock-in, adeno-associated virus–mediated hepatic expression or direct administration of human CRP. Mechanistically, CRP does not act via its cellular receptor Fcγ receptor 2B to inhibit the early phase injury to hepatocytes induced by acetaminophen; instead, CRP acts via factor H to inhibit complement overactivation on already injured hepatocytes, thereby suppressing the late phase amplification of inflammation likely mediated by C3a-dependent actions of neutrophils. Importantly, CRP treatment effectively alleviated AILI with a significantly extended therapeutic time window than that of N-acetyl cysteine. Our results thus identify CRP as a crucial checkpoint that limits destructive activation of complement in acute liver injury, and we argue that long-term suppression of CRP expression or function might increase the susceptibility to AILI.
登录
查看更多内容
影响因子:
7.3
作者:
Jia ZK;Li HY;Liang YL;Potempa LA;Ji SR;Wu Y
通讯作者:
Wu Y
影响因子:
16.6
作者:
Braig D;Nero TL;Koch HG;Kaiser B;Wang X;Thiele JR;Morton CJ;Zeller J;Kiefer J;Potempa LA;Mellett NA;Miles LA;Du XJ;Meikle PJ;Huber-Lang M;Stark GB;Parker MW;Peter K;Eisenhardt SU
通讯作者:
Eisenhardt SU
影响因子:
4.8
作者:
Ji, Shang-Rong;Wu, Yi;Zhao, Jing
通讯作者:
Zhao, Jing
DOI:
10.1155/2013/379040
发表时间:
2013-09-14
期刊:
ISRN inflammation
影响因子:
--
作者:
Du Clos TW
通讯作者:
Du Clos TW
DOI:
10.1084/jem.192.9.1353
发表时间:
2000-11-06
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Gershov D;Kim S;Brot N;Elkon KB
通讯作者:
Elkon KB